Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
The Lancet. Digital Health
|
September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial
Robert Gross, Justin Ritz, Michael D Hughes, et al.
Annals of Internal Medicine
|
November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial
Karen T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Contemporary Clinical Trials
|
March 27, 2025
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Mark J Giganti, Kara W Chew, Carlee Moser, et al.
Scientific Reports
|
March 20, 2026
Association of long COVID with health-related quality-of-life outcomes
Malini M Gandhi, Carlee Moser, Judith S Currier, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
October 27, 2018
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
Sharon A Riddler, Lu Zheng, Christine M Durand, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
The Lancet. Digital Health
|
September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial
Robert Gross, Justin Ritz, Michael D Hughes, et al.
Annals of Internal Medicine
|
November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial
Karen T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Contemporary Clinical Trials
|
March 27, 2025
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Mark J Giganti, Kara W Chew, Carlee Moser, et al.
Scientific Reports
|
March 20, 2026
Association of long COVID with health-related quality-of-life outcomes
Malini M Gandhi, Carlee Moser, Judith S Currier, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
October 27, 2018
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
Sharon A Riddler, Lu Zheng, Christine M Durand, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Page
of 6